MERCK & CO., INC.

(MRK)
  Report
Delayed Nyse  -  04:03 2022-08-12 pm EDT
91.02 USD   +2.35%
08/11First Patient Dosed in ALX Oncology's Mid-Stage Trial of Colorectal Cancer Combination Therapy
MT
08/10Starpharma, Merck & Co. Ink New Drug Delivery Research Deal
MT
08/09Merck's Diabetes Drug Januvia Found to Contain Potential Carcinogen; Shares Briefly Slide Into Negative Territory
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Other Pharmaceuticals
04:23aNovartis fails again to reuse anti-inflammatory drug to treat lung cancer
RE
01:15aRoche Unveils New Diagnostic Test for COVID-19 Immune Response
MT
01:00aRoche Launches New Diagnostic Test for the Better Understanding of Immune Response to S..
CI
08/14Switzerland Negotiating Pharmaceutical Trade Deal With US
MT
08/13U.S. and Switzerland working on facilitating pharma trade - U.S. ambassador
RE
08/12Biotech stocks pin bounce back hopes on M&A boost
RE
08/12Pfizer Says Pneumococcal Disease Vaccine Has Potential to Provide Broadest Serotype Cov..
MT
08/12Pfizer Inc. Announces Positive Top-Line Results from Phase 3 Study of 20-Valent Pneumoc..
CI
08/12Johnson & Johnson To Discontinue Selling Talc-Based Baby Powder In 2023
MT
08/12Johnson & Johnson's Janssen Secures License to WuXi's TESSA Technology
MT
08/12European shares rise as healthcare, leisure stocks gain
RE
08/12GSK, Sanofi, Haleon Shares Recover Some Recent Losses After Zantac Drug Responses
DJ
08/12Haleon Says It Hasn't Been Notified About Litigation on Zantac Drug -- Update
DJ
08/12Roche Announces U.S. FDA approval of Xofluza to treat influenza in children aged five y..
CI
08/12Haleon Says it Hasn't Been Notified About Litigation on Zantac Drug
DJ
08/11AbbVie's Eye Disease Drug Recommended For Extended Use In British Healthcare System
MT
08/11Roche's Genentech Gets US FDA Nod For Influenza Drug In Children Aged Five To 12
MT
08/11US Stocks Close Mixed Thursday Following Surprise Producer Price Drop
MT
08/11US Stocks Close Mixed Thursday Following Surprise Producer Price Drop
MT
08/11Johnson & Johnson to Discontinue Talc-Based Baby Powder in 2023
DJ
08/11GSK, Sanofi and Haleon shares slump on Zantac litigation concerns
RE
08/11GENENTECH : FDA Approves Xofluza to Treat Influenza in Children Aged 5 and Older
DJ
08/11Senate Finance Committee looks at Amgen taxes, widening drugmaker probe
RE
08/11Sanofi, GSK, Pfizer Shares Fall Amid Growing Concerns Around Zantac Litigation in US
MT
08/11MeiraGTx's Q2 Net Loss Per Diluted Share Widens; Expects Sufficient Capital Through Q4 ..
MT
08/11Eli Lilly and Company Announces Executive Changes
CI
08/11ROCHE HOLDINGS AG : Deutsche Bank reiterates its Neutral rating
MD
08/11GSK, Sanofi and Haleon shares slump on Zantac litigation concerns
RE
08/11Roche Obtains US FDA Approval For Expansion Of Ventana Diagnostic Test
MT
08/11Roche Holding Ag Announces U.S. FDA Approval of A Label Expansion for the VENTANA MMR R..
CI
08/11Roche Receives FDA Approval for VENTANA MMR RxDx Panel to identify dMMR solid tumour pa..
CI
08/10Roche Enters Team-Up to Evaluate Pancreatic Cancer Drug Combo
MT
08/10Caladrius Biosciences, Inc. Announces Collaboration Agreement with F. Hoffmann-La Roche..
CI
08/10ROCHE HOLDINGS AG : Goldman Sachs reaffirms its Buy rating
MD
08/10Roche's Rare Blood Disease Drug Wins Priority Review Tag In China
MT
08/10Pfizer Managing Director Tenders Resignation
MT
08/09Novavax tumbles 30% as waning COVID-19 vaccine demand hits outlook
RE
08/09Global Blood Therapeutics Downgraded by RBC to Sector Perform From Outperform, Price Ta..
MT
08/09Novavax tumbles 31% as waning COVID vaccine demand hits revenue forecast
RE
08/09EU Health Agency Starts Real-time Review of Pfizer-BioNTech's Variant-specific COVID-19..
MT
08/09Arecor Granted EU Patent Protection for High-Concentration Version of AbbVie's Adalimum..
MT
08/09BioPharma Credit To Receive Loan Prepayment Following Pfizer's Takeover Of Global Blood..
MT
08/08Pfizer, Valneva Commence Late-stage Study of Lyme Disease Vaccine Candidate
MT
08/08Johnson & Johnson Announces Executive Changes
CI
08/08Novavax sinks after halving sales forecast on low vaccine demand, supply glut
RE
08/08Pfizer, Valneva Initiate Phase 3 Study of Lyme Disease Vaccine VLA15
DJ
08/08Pfizer Strikes $5.4 Billion Buyout Deal For Global Blood Therapeutics, Eyeing Sickle Ce..
MT
08/08SECTOR UPDATE : Health Care Stocks Edge Higher Early Monday
MT
08/08BioNTech ADRs Fall 10% On Lower 2Q Revenue
DJ
08/08SECTOR UPDATE : Health Care
MT
1  2  3  4  5  6  7  8  9  10Next
Official Publications
Upcoming event on MERCK & CO., INC.